3hon MSN
The Highly Anticipated “Triple Agonist” Weight Loss Med Is Almost Here—What Doctors Say About It
Phase 3 clinical trial results are out now.
The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...
39mon MSN
Trump expected to sign an order moving to reclassify cannabis and open up medical potential
President Donald Trump is expected to sign an executive order that would fast-track the reclassification of cannabis and ...
Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
The U.S. Food and Drug Administration has approved GSK's add-on drug to treat asthma and a chronic inflammatory sinus condition, the drugmaker said on Tuesday, paving the way for a less frequently ...
Dec 15 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in ...
On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...
Scripps News on MSN
Drug for low sexual desire gets first-ever OK for postmenopausal women
FDA approves Addyi for low sexual desire in postmenopausal women under 65, expanding use beyond premenopausal patients for ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
President Donald Trump said Monday that the White House is “very strongly” considering signing an executive order to ...
For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...
Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results